Yang Shao

Geneseeq Technology Inc. - Nanjing Geneseeq Technology Inc.

Nanjing, Jiangsu

China

Nanjing Medical University - School of Public Health

Nanjing

China

SCHOLARLY PAPERS

3

DOWNLOADS

54

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (3)

1.

Mutation of FGFR1 and MED12 of Cell-Free DNA Contribute to Early Diagnostics of Tumor-Induced Osteomalacia

Number of pages: 39 Posted: 10 Dec 2018
Chinese Academy of Medical Sciences - Department of Orthopaedic Surgery, Chinese Academy of Medical Sciences - Department of Orthopaedic Surgery, Chinese Academy of Medical Sciences - Department of Orthopaedic Surgery, Wenzhou Medical University, Chinese Academy of Medical Sciences - Peking Union Medical College, Geneseeq Technology Inc., Geneseeq Technology Inc. - Nanjing Geneseeq Technology Inc., Chinese Academy of Medical Sciences - Central Laboratory, Wenzhou Medical University, Geneseeq Technology Inc., Chinese Academy of Medical Sciences - Department of Orthopaedic Surgery, Geneseeq Technology Inc. - Nanjing Geneseeq Technology Inc., Chinese Academy of Medical Sciences - Department of Orthopaedic Surgery, Chinese Academy of Medical Sciences - Central Laboratory, Chinese Academy of Medical Sciences - Central Laboratory, Qingdao University, Beijing Eki Information Technology Co., Ltd., Geneseeq Technology Inc. - Nanjing Geneseeq Technology Inc., Chinese Academy of Medical Sciences - Department of Orthopaedic Surgery, Chinese Academy of Medical Sciences - Department of Orthopaedic Surgery, Chinese Academy of Medical Sciences - Department of Orthopaedic Surgery, Chinese Academy of Medical Sciences - Department of Orthopaedic Surgery, Chinese Academy of Medical Sciences - Department of Orthopaedic Surgery, Chinese Academy of Medical Sciences - Department of Orthopaedic Surgery, Chinese Academy of Medical Sciences - Department of Orthopaedic Surgery, Chinese Academy of Medical Sciences - Department of Orthopaedic Surgery, Chinese Academy of Medical Sciences - Department of Endocrinology, Chinese Academy of Sciences (CAS), Wenzhou Medical University, Chinese Academy of Medical Sciences - Department of Orthopaedic Surgery, Chinese Academy of Medical Sciences - Department of Endocrinology, Chinese Academy of Medical Sciences - Department of Orthopaedic Surgery, affiliation not provided to SSRN, affiliation not provided to SSRN, Chinese Academy of Medical Sciences - Department of Orthopaedic Surgery, Chinese Academy of Medical Sciences - Department of Orthopaedic Surgery and Chinese Academy of Medical Sciences - Central Laboratory
Downloads 22 (555,103)

Abstract:

Loading...

tumor-induced osteomalacia; phosphaturic mesenchymal tumors; cell-free DNA; next-generation sequencing; fibroblast growth factor receptor-1; mediator complex subunit 12

2.

Wait-and-See Treatment Strategy and Genomic Alternations Associated with Progression in Lung Adenocarcinoma with Pleural Dissemination

Number of pages: 28 Posted: 09 May 2019
Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangzhou University of Chinese Medicine, Geneseeq Technology Inc., Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Geneseeq Technology Inc., Geneseeq Technology Inc., Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Geneseeq Technology Inc. - Nanjing Geneseeq Technology Inc., Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute and Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute
Downloads 18 (580,753)

Abstract:

Loading...

Lung adenocarcinoma, pleural dissemination, wait-and-see, genome instability, progression

3.

New Role of Tumor Mutation Burden as a Predictor to Chemo/Targeted Therapy in Advanced Non-Small Cell Lung Cancer

Number of pages: 25 Posted: 04 Oct 2019
Chinese Academy of Sciences (CAS) - Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences (CAS) - Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences (CAS) - Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences (CAS) - Institute of Cancer and Basic Medicine (ICBM), Geneseeq Technology Inc. - Nanjing Geneseeq Technology Inc., Chinese Academy of Sciences (CAS) - Institute of Cancer and Basic Medicine (ICBM) and Chinese Academy of Sciences (CAS) - Institute of Cancer and Basic Medicine (ICBM)
Downloads 14 (607,091)

Abstract:

Loading...

Tumor mutation burden (TMB); Predictive factor; Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI); Chemotherapy; Non-small cell lung cancer (NSCLC)